Boston Scientific Thinks Big In HF Provider Risk-Share Plan
Value-based care, leveraging digital health and analytics, is now viewed as the all-important ingredient in sustainable health care delivery. With that in mind, Boston Scientific and global professional services company Accenture have recently joined forces in a total-cost-of-care heart failure project that is rewarded on patient outcomes.
You may also be interested in...
Johnson & Johnson's Ashley McEvoy explains how the global medtech business should change, seen through the lens of the coronavirus pandemic.
COVID-19 business volatility continues to impact the medtech industry, but Royal Philips is targeting modest comparable sales growth for 2020 after posting quarterly growth of 10%.
Germany’s COVID-19 testing strategy now permits the use and reimbursement of coronavirus antigen tests.